Enovis falls on downbeat 2022 forecast

** Enovis Corp's shares  ENOV.N  slide 2.3% to $48.36 
    ** Medical device maker expects FY adjusted profit in the
range of $2.20 per share to $2.25 per share, lower than
analysts' estimates of $2.26 - Refinitiv IBES data
    ** Co posted Q3 loss of $1.22 per share from continuing
operation, compared with a loss of $0.26 per share a year ago
 urn:newsml:reuters.com:*:nGNE6JQKpj
    ** Including session losses, stock down ~39% YTD
 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))

Recent news on Enovis

See all news